NDA 019693

LILLY

FDA Drug Application

Application #019693

Application Sponsors

NDA 019693

LILLY

Marketing Status

• Discontinued: 001
• Discontinued: 002
• Discontinued: 003

Application Products

001	TABLET, EXTENDED RELEASE;ORAL	EQ 50MG BASE	0	DECABID	INDECAINIDE HYDROCHLORIDE
002	TABLET, EXTENDED RELEASE;ORAL	EQ 75MG BASE	0	DECABID	INDECAINIDE HYDROCHLORIDE
003	TABLET, EXTENDED RELEASE;ORAL	EQ 100MG BASE	0	DECABID	INDECAINIDE HYDROCHLORIDE

FDA Submissions

TYPE 1; Type 1 - New Molecular Entity

ORIG

1

AP

1989-12-29

STANDARD

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 19693
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)